American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

美国临床肿瘤学会更新了关于使用药物干预（包括他莫昔芬、雷洛昔芬和芳香化酶抑制剂）降低乳腺癌风险的临床实践指南。